Xia Yin

Title: Innovations by Xia Yin in Sustained-Release Microsphere Technology

Introduction

Xia Yin is an accomplished inventor based in Zhuhai, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of sustained-release drug delivery systems. His innovative work focuses on enhancing the efficacy and delivery of medications.

Latest Patents

Xia Yin holds a patent for an "Aripiprazole sustained-release microsphere and preparation method therefor." This invention provides a novel microsphere that comprises aripiprazole and polylactide-glycolide. The microsphere features a spherical reticular skeleton structure, with reticular micropores distributed across its surface, allowing for the effective encapsulation of aripiprazole within these micropores. The average particle diameter of the microsphere is less than 20 μm, making it suitable for administration through a 5 gauge needle. The content of aripiprazole within the microsphere ranges from 65% to 80% of its total weight, showcasing its potential for sustained drug release.

Career Highlights

Xia Yin is currently associated with Zhuhai Livzon Microsphere Technology Co. Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key player in the field of microsphere technology, contributing to innovative solutions in drug delivery.

Collaborations

Xia collaborates with notable colleagues, including Bin Chen and Yanqing Wang, who contribute to his research endeavors. Their combined expertise enhances the development of cutting-edge technologies in the pharmaceutical sector.

Conclusion

Xia Yin's innovative work in sustained-release microsphere technology represents a significant advancement in drug delivery systems. His contributions are poised to improve therapeutic outcomes for patients requiring aripiprazole treatment.